Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Shining a light on orphan medicines

Shining a light on orphan medicines Demonstrate an unmet medical need. As we know from observing the furore surrounding the development and launch of BioMarin's Firdapse for Lambert–Eaton myasthenic syndrome (Nicholl DJ, Hilton-Jones D, ... Biomarin Europe replies.

DNA repair: still promising in cancer?

CEP-9722. Cephalon. phase I. BMN 673 (LT 673). BioMarin. phase I.

Drug delivery

Development, Commercialisation Licence. 55. Pfizer/BioMarin. Manufacturing facilities. Divestment. 49. Medivir/Meda. Xerese for herpes labialis.

Triple negative breast cancer

There is also BMN 673, a small molecule inhibitor under phase I/II development with BioMarin.

Pompe drug wins orphan status

The US Food and Drug Administration has granted orphan drug status to BioMarin Pharmaceutical's investigational therapy for Pompe disease. ... BioMarin added the experimental Pompe treatment to its pipeline when it acquired the privately-held biotech

[ Previous 5 results ] 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards